Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Joshua Hill, MD
CONTACT
Lead
Fred Hutchinson Cancer Center
With
OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients receive LUNAR-COV19 intramuscularly (IM) on days 1, 29 and 113 in the absence of medical conditions or unacceptable toxicity. Additionally, patients undergo nasal swab at screening and at time of suspected SARS-CoV-2 infection, as well as blood sample collection throughout the study. ARM II: Patients receive SARS-CoV-2 Comirnaty IM on days 1, 29 and 113 in the absence of medical conditions or unacceptable toxicity. Additionally, patients undergo nasal swab at screening and at time of suspected SARS-CoV-2 infection, as well as blood sample collection throughout the study. After completion of study treatment, patients are followed up at days 115, 120, 127, 141 and 281.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
